Confusing signals: Recent progress in CTLA-4 biology

Trends in Immunology

Volumn 36, Issue 2, 2015, Pages 63-70

  Walker, Lucy S K ^a   Sansom, David M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CD28; Costimulation; CTLA 4; T cell activation; T cell tolerance

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROTEIN KINASE C ETA; LIGAND; PROTEIN BINDING;

ANTIGEN FUNCTION; CELL MOTILITY; CELL SURFACE; CELLULAR DISTRIBUTION; CYTOPLASM; DOWN REGULATION; HUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTING CELL; CELL MOTION; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN DOMAIN; PROTEIN TRANSPORT;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MOVEMENT; CTLA-4 ANTIGEN; DOWN-REGULATION; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84961289524     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.12.001     Document Type: Review

References (97)

1. Waterhouse P., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270:985-988.
2. Tivol E.A., et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 3:541-547.
3. Takahashi T., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000, 192:303-310.
4. Read S., et al. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000, 192:295-302.
5. Mandelbrot D.A., et al. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 1999, 189:435-440.
6. Tivol E.A., et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 1997, 158:5091-5094.
7. Tai X., et al. Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13756-13761.
8. Teft W.A., et al. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 2006, 24:65-97.
9. Darlington P.J., et al. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation. J. Immunol. 2005, 175:996-1004.
10. Stamper C.C., et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 2001, 410:608-611.
11. Yu C., et al. Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering. J. Biol. Chem. 2011, 286:6685-6696.
12. Lee K.M., et al. Molecular basis of T cell inactivation by CTLA-4. Science 1998, 282:2263-2266.
13. Calvo C.R., et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J. Exp. Med. 1997, 186:1645-1653.
14. Schneider H., et al. CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization. Eur. J. Immunol. 2008, 38:40-47.
15. Schneider H., et al. A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling. Eur. J. Immunol. 2001, 31:2042-2050.
16. Hu H., et al. Src kinases Fyn and Lck facilitate the accumulation of phosphorylated CTLA-4 and its association with PI-3 kinase in intracellular compartments of T-cells. Biochem. Biophys. Res. Commun. 2001, 288:573-578.
17. Stein P.H., et al. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase. Mol. Cell. Biol. 1994, 14:3392-3402.
18. Marengere L.E., et al. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996, 272:1170-1173.
19. Schneider H., Rudd C.E. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition. Biochem. Biophys. Res. Commun. 2000, 269:279-283.
20. Yokosuka T., et al. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 2010, 33:326-339.
21. Schneider H., et al. CTLA-4 activation of phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death. PLoS ONE 2008, 3:e3842.
22. Parry R.V., et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 2005, 25:9543-9553.
23. Chuang E., et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 2000, 13:313-322.
24. Baroja M.L., et al. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 2002, 168:5070-5078.
25. Wakamatsu E., et al. Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:1023-1028.
26. Friedline R.H., et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med. 2009, 206:421-434.
27. Corse E., Allison J.P. Cutting edge: CTLA-4 on effector T cells inhibits in trans. J. Immunol. 2012, 189:1123-1127.
28. Stumpf M., et al. Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function. Eur. J. Immunol. 2014, 44:1737-1746.
29. Kong K.F., et al. Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function. Nat. Immunol. 2014, 15:465-472.
30. Hoefen R.J., Berk B.C. The multifunctional GIT family of proteins. J. Cell Sci. 2006, 119:1469-1475.
31. Mead K.I., et al. Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells. J. Immunol. 2005, 174:4803-4811.
32. Missy K., et al. AlphaPIX Rho GTPase guanine nucleotide exchange factor regulates lymphocyte functions and antigen receptor signaling. Mol. Cell. Biol. 2008, 28:3776-3789.
33. Onishi Y., et al. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10113-10118.
34. Schneider H., et al. Reversal of the TCR stop signal by CTLA-4. Science 2006, 313:1972-1975.
35. Ruocco M.G., et al. Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects. J. Clin. Invest. 2012, 122:3718-3730.
36. Miska J., et al. Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance. J. Exp. Med. 2014, 211:441-456.
37. Lu Y., et al. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal. Blood 2012, 120:4560-4570.
38. Fife B.T., et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 2009, 10:1185-1192.
39. Pentcheva-Hoang T., et al. Cytotoxic T lymphocyte antigen-4 blockade enhances antitumor immunity by stimulating melanoma-specific T-cell motility. Cancer Immunol. Res. 2014, 2:970-980.
40. Simpson T.R., et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J. Exp. Med. 2013, 210:1695-1710.
41. Bulliard Y., et al. Activating Fc gamma receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. J. Exp. Med. 2013, 210:1685-1693.
42. Mirenda V., et al. Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood 2007, 109:2968-2977.
43. Jain N., et al. CD28 and ITK signals regulate autoreactive T cell trafficking. Nat. Med. 2013, 19:1632-1637.
44. Singleton K.L., et al. Itk controls the spatiotemporal organization of T cell activation. Sci. Signal. 2011, 4:ra66.
45. Liang Y., et al. The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells. Nat. Immunol. 2013, 14:858-866.
46. Tan Y.X., et al. Inhibition of the kinase Csk in thymocytes reveals a requirement for actin remodeling in the initiation of full TCR signaling. Nat. Immunol. 2014, 15:186-194.
47. Bachmann M.F., et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 1999, 163:1128-1131.
48. Bachmann M.F., et al. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 2001, 31:450-458.
49. Homann D., et al. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J. Virol. 2006, 80:270-280.
50. Walker L.S., Sansom D.M. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat. Rev. Immunol. 2011, 11:852-863.
51. Cederbom L., et al. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 2000, 30:1538-1543.
52. Oderup C., et al. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 2006, 118:240-249.
53. Misra N., et al. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 2004, 172:4676-4680.
54. Wing K., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322:271-275.
55. Schmidt E.M., et al. CTLA-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. J. Immunol. 2009, 182:274-282.
56. Shin D.S., et al. Regulatory T cells suppress CD4+ T cells through NFAT-dependent transcriptional mechanisms. EMBO Rep. 2014, 15:991-999.
57. Kim J.M., et al. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 2007, 8:191-197.
58. Schildknecht A., et al. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:199-203.
59. Penaloza-MacMaster P., et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J. Exp. Med. 2014, 211:1905-1918.
60. Kastenmuller W., et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J. Immunol. 2011, 187:3186-3197.
61. Pentcheva-Hoang T., et al. B7-1 and b7-2 selectively recruit ctla-4 and CD28 to the immunological synapse. Immunity 2004, 21:401-413.
62. Qureshi O.S., et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011, 332:600-603.
63. Davis D.M. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat. Rev. Immunol. 2007, 7:238-243.
64. Meloty-Kapella L., et al. Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev. Cell 2012, 22:1299-1312.
65. Marston D.J., et al. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat. Cell Biol. 2003, 5:879-888.
66. Moran A.E., et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 2011, 208:1279-1289.
67. Lee H.M., et al. A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity 2012, 37:475-486.
68. Cobbold S.P., et al. Connecting the mechanisms of T-cell regulation: dendritic cells as the missing link. Immunol. Rev. 2010, 236:203-218.
69. Tai X., et al. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 2012, 119:5155-5163.
70. Yamaguchi T., et al. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E2116-E2125.
71. Kataoka H., et al. CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4. Int. Immunol. 2005, 17:421-427.
72. Masteller E.L., et al. Structural analysis of CTLA-4 function in vivo. J. Immunol. 2000, 164:5319-5327.
73. Iida T., et al. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4- containing lysosomes upon activation of CD4+ T cells. J. Immunol. 2000, 165:5062-5068.
74. Kaur S., et al. Comparison of the intracellular trafficking itinerary of ctla-4 orthologues. PLoS ONE 2013, 8:e60903.
75. Zhang Y., Allison J.P. Interaction of CTLA-4 with AP-50, a clathrin-coated pit adaptor protein. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9273-9278.
76. Kozik P., et al. A screen for endocytic motifs. Traffic 2010, 11:843-855.
77. Schneider H., et al. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J. Immunol. 1999, 163:1868-1879.
78. Darlington P.J., et al. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. J. Exp. Med. 2002, 195:1337-1347.
79. Valk E., et al. T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor. Immunity 2006, 25:807-821.
80. Banton M.C., et al. Rab8 binding to immune cell-specific adaptor LAX facilitates formation of trans-Golgi network-proximal CTLA-4 vesicles for surface expression. Mol. Cell. Biol. 2014, 34:1486-1499.
81. Qureshi O.S., et al. Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation. J. Biol. Chem. 2012, 287:9429-9440.
82. Egen J.G., Allison J.P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002, 16:23-35.
83. Linsley P.S., et al. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996, 4:535-543.
84. Wang C.J., et al. Cutting edge: cell-extrinsic immune regulation by ctla-4 expressed on conventional T cells. J. Immunol. 2012, 189:1118-1122.
85. Zheng Y., et al. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 2008, 181:1683-1691.
86. Gao J.F., et al. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells. Eur. J. Immunol. 2011, 41:2699-2708.
87. Kuehn H.S., et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014, 345:1623-1627.
88. Schubert D., et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat. Med. 2014, 20:1410-1416.
89. Shiratori T., et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 1997, 6:583-589.
90. Chuang E., et al. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 1997, 159:144-151.
91. Bradshaw J.D., et al. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry 1997, 36:15975-15982.
92. Baroja M.L., et al. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation. J. Immunol. 2000, 164:49-55.
93. Cinek T., et al. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4. J. Immunol. 2000, 164:5-8.
94. Nakaseko C., et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 1999, 190:765-774.
95. Chuang E., et al. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J. Immunol. 1999, 162:1270-1277.
96. Collins A.V., et al. The interaction properties of costimulatory molecules revisited. Immunity 2002, 17:201-210.
97. Fuertes Marraco S.A., et al. A stepwise protocol to coat aAPC beads prevents out-competition of anti-CD3 mAb and consequent experimental artefacts. J. Immunol. Methods 2012, 385:90-95.